We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Chip-Based Mobile Blood Diagnosis Takes Only Minutes

By LabMedica International staff writers
Posted on 22 Oct 2009
New analysis technology takes just a few minutes, and physicians know immediately whether there are any pathogens in the blood. More...
The improved marker-free technique provides the basis for faster analysis, whether in a hospital or for mobile blood donations.

If a person loses a large amount of blood, the consequences can be critical. That is why adequate quantities of donated blood have to be kept available in hospitals and blood banks. In Egypt, doctors collect blood by traveling to towns and villages and conducting blood donation sessions in a laboratory bus. The problem is that 25% of the samples taken contain pathogens, including HIV, hepatitis, and syphilis. As these diseases can be passed on in transfusions, the contaminated blood cannot be used. Conventional fast tests are not suitable in most cases for mobile use.

In the near future, a rapid and robust analysis technique should help. A few drops of blood could be tested in the bus to check whether it can be used. Only if the result is positive will physicians take a larger quantity from the donor. The basis for this has been provided by research scientists from the Fraunhofer Institute for Biomedical Engineering IBMT (Sankt Ingbert, Germany) under a European Union (EU) project also involving the Egyptian company Vacsera (Giza), Mivitec, GmbH (Munich, Germany), the Institute for Analytical Sciences ISAS (Dortmund, Germany), and the University of Lausitz (Germany). "Our consortium has developed a glass chip which has antibodies on it. Tiny surface oscillations are induced in the chip. If the relevant virus binds with an antibody, the oscillation changes,” explained Dr. Thomas Velten, head of department at the IBMT.

The technique is not new, but the new chip that has been developed offers advantages. Usually there is only one measurement field and a reference field next to it, positioned a just a few millimeters apart. But the temperature there can be different. On the new chip, the measurement and reference fields are divided into narrow strips, which in each case are located right next to each other. As a result, the chip is more resistant to fluctuations in temperature. Moreover, the new chip consists of four analysis squares, which means that the blood can be examined for four different pathogens during each test.

It has also been difficult up until now for laboratory workers to avoid contact with the blood and protect themselves from infections while conducting tests in the bus. The researchers at the IBMT have therefore encapsulated the chip. This makes the blood follow a defined course on the chip, protecting the user.

A first prototype of the measurement device is being presented at the Medica trade fair from November 18-21, 2009, in Düsseldorf, Germany.

Dr. Velten estimates that the device could come onto the market in approximately three years' time.

Related Links:

Fraunhofer Institute for Biomedical Engineering IBMT
Vacsera
Mivitec
Institute for Analytical Sciences ISAS



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study design and workflow (Parankusham H, Vanderlip C, Birkenbihl C, et al. A two-stage plasma biomarker algorithm reduces amyloid PET use and the p-Tau217 gray zone. Annals of Clinical and Translational Neurology. Published online October 19, 2026. doi:10.1002/acn3.70560)

Two-Step Blood Testing Approach Reduces Uncertainty in Amyloid Assessment

Blood-based biomarkers offer a more accessible, less expensive way to detect Alzheimer’s-related brain changes than traditional methods such as amyloid-beta positron emission tomography (Aβ-PET).... Read more

Molecular Diagnostics

view channel
Image: Tumor DNA is extracted from a pathology sample, and normal DNA is extracted from the buffy coat. Both samples undergo WGS to generate the patient-specific mutational signature. At each follow-up, ctDNA extracted from plasma undergoes WGS and is analyzed using a patient-derived signature and an artificial intelligence (AI) pattern recognition algorithm. FFPE: formalin fixed, paraffin embedded. (Snuderl M, Smadbeck J, Wilkins R, et al. The Journal of Molecular Diagnostics, 2026. DOI: 10.1016/j.jmoldx.2026.07.003)

Liquid Biopsy Detects Lung Cancer Recurrence Signals Months Before Imaging

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and remains a major cause of cancer-related death. Early-stage tumors are often treated surgically, but recurrence can still occur... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.